AbbVie Inc.
Explore AbbVie Inc.
Core profile pages, annual revenue records, and related research hubs for this company.
CorpDigest
AbbVie Inc.
Explore AbbVie Inc.
Core profile pages, annual revenue records, and related research hubs for this company.
Annual Revenue
FY2024 Revenue
$56.3B
▲ 3.6% vs FY2023 ($54.3B)
Net Income: $4.3B
Source: Annual report / company filing
AbbVie Inc. reported $56.3B in revenue for fiscal year 2024. This represents a growth of 3.6% compared to the 2023 figure of $54.3B. In 2025, revenue increased to $61.2B.
Skyrizi and Rinvoq grew fast enough to replace Humira's lost sales, returning the company to growth.
| Year | Revenue | Net Income | YoY Change |
|---|---|---|---|
| FY2025 | $61.2B | — | +8.6% |
| FY2024 | $56.3B | $4.3B | +3.6% |
| FY2023 | $54.3B | — | -6.4% |
| FY2022 | $58.1B | — | +3.3% |
| FY2021 | $56.2B | — | +22.7% |
| FY2020 | $45.8B | — | — |
Source: SEC EDGAR filings, annual earnings releases, and verified financial disclosures.